Sonic: a randomized, double-blind, controlled trial comparing infliximab and infliximab plus azathioprine to azathioprine in patients with Crohn's disease naive to Immunomodulators and biologic therapy

被引:36
|
作者
Sandborn, W.
Rutgeerts, P.
Reinisch, W.
Kornbluth, A.
Lichtiger, S.
D'Haens, G.
van der Woude, C.
Diamond, R.
Broussard, D.
Colombel, J.
机构
[1] Mayo Clin, Rochester, MN USA
[2] Univ Hosp Gasthuisberg, B-3000 Leuven, Belgium
[3] Univ Hosp Vienna, Vienna, Austria
[4] Mt Sinai Med Ctr, New York, NY 10029 USA
[5] Imelda Ziekenhuis, Bonheiden, Belgium
[6] Erasmus MC, Rotterdam, Netherlands
[7] Centocor Inc, Horsham, PA USA
[8] CHU Lille, F-59037 Lille, France
来源
关键词
D O I
10.14309/00000434-200809001-01117
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1117
引用
收藏
页码:S436 / S436
页数:1
相关论文
共 50 条
  • [21] Actinomyces Osteomyelitis of the Mandible Complicating Infliximab and Azathioprine Therapy for Crohn's Disease
    Thimmapuram, Jayaram
    Oosterveen, Scott
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S357 - S357
  • [22] Steroid-independent Crohn's disease patients also benefit from combination therapy of infliximab plus azathioprine
    Van Den Brande, Jan M. H.
    Peppelenbosch, Maikel P.
    GASTROENTEROLOGY, 2006, 131 (04) : 1362 - 1363
  • [23] AZATHIOPRINE AS A MAINTENANCE TREATMENT FOR CROHN DISEASE - DOUBLE-BLIND WITHDRAWAL TRIAL
    ODONOGHUE, DP
    DAWSON, AM
    POWELLTUCK, J
    BOWN, RL
    BUCKELL, NA
    BURNHAM, WR
    GOULD, SR
    WILLIAMS, CB
    LENNARDJONES, JE
    GASTROENTEROLOGY, 1978, 74 (05) : 1138 - 1138
  • [24] Addition of Metronidazole to Azathioprine for the Prevention of Postoperative Recurrence of Crohn's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
    Manosa, Miriam
    Cabre, Eduard
    Bernal, Isabel
    Esteve, Maria
    Garcia-Planella, Esther
    Ricart, Elena
    Penalva, Mireia
    Cortes, Xavier
    Boix, Jaume
    Pinol, Marta
    Gassull, Miquel A.
    Domenech, Eugeni
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (09) : 1889 - 1895
  • [25] Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease
    Ochsenkühn, T
    Göke, B
    Sackmann, M
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (08): : 2022 - 2025
  • [26] Randomized, double-blind, placebo-controlled trial of infliximab in patients with polymyositis and dermatomyositis
    Coyle, K.
    Pokrovnichka, A.
    French, K.
    Joe, G.
    Shrader, J.
    Swan, L.
    Cabalar, I.
    Harris-Love, M.
    Plotz, P.
    Miller, F.
    Gourley, M.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S923 - S924
  • [27] Pneumocystis Pneumonia During Combined Therapy of Infliximab, Corticosteroid, and Azathioprine in a Patient with Crohn’s Disease
    Soichi Itaba
    Tsutomu Iwasa
    Yojiro Sadamoto
    Toshifumi Nasu
    Tadashi Misawa
    Koji Inoue
    Hidehiko Shimokawa
    Kazuhiko Nakamura
    Ryoichi Takayanagi
    Digestive Diseases and Sciences, 2007, 52 : 1438 - 1441
  • [28] Pneumocystis pneumonia during combined therapy of infliximab, corticosteroid, and azathioprine in a patient with Crohn's disease
    Itaba, Soichi
    Iwasa, Tsutomu
    Sadamoto, Yojiro
    Nasu, Toshifumi
    Misawa, Tadashi
    Inoue, Koji
    Shimokawa, Hidehiko
    Nakamura, Kazuhiko
    Takayanagi, Ryoichi
    DIGESTIVE DISEASES AND SCIENCES, 2007, 52 (06) : 1438 - 1441
  • [29] Predictors of Infliximab Failure After Azathioprine Withdrawal in Crohn's Disease Treated With Combination Therapy
    Oussalah, Abderrahim
    Chevaux, Jean-Baptiste
    Fay, Renaud
    Sandborn, William J.
    Bigard, Marc-Andre
    Peyrin-Biroulet, Laurent
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (05): : 1142 - 1149
  • [30] BCG-specific lymphocyte proliferation in patients with Crohn's disease with scheduled azathioprine and infliximab maintenance therapy
    Oya, V
    Davanco, T.
    Coy, C.
    Da Silva, M.
    Moreno, Y.
    Sgarbieri, V
    Costa-Pinto, E.
    Vilela, M.
    ALLERGY, 2011, 66 : 113 - 114